These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19495756)

  • 1. Living on the edge: immune cells and immunopathology in the intestinal mucosa.
    Brunner T
    Semin Immunopathol; 2009 Jul; 31(2):143-4. PubMed ID: 19495756
    [No Abstract]   [Full Text] [Related]  

  • 2. [In situ expression of interleukin-10 messenger RNA in Crohn disease and ulcerative colitis].
    Autschbach F; Schürmann G; Braunstein J; Niemir Z; Wallich R; Otto HF; Meuer SC
    Verh Dtsch Ges Pathol; 1996; 80():218. PubMed ID: 9065011
    [No Abstract]   [Full Text] [Related]  

  • 3. [Colitis--newer aspects upon ulcerative colitis and Crohn's disease in the colon].
    Lakartidningen; 1973 Sep; 70(36):3051-71. PubMed ID: 4151353
    [No Abstract]   [Full Text] [Related]  

  • 4. [Features of inflammation of the mucosa of the large intestine in nonspecific ulcerative colitis and Crohn's disease].
    Novikova AV; Shcherbakov IT; Ol'shanskiĭ IaO; Iurkov MM; Levitan MKh
    Arkh Patol; 1982; 44(9):31-9. PubMed ID: 6756359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell activation and proliferation in the large intestine of patients with Crohn's disease or ulcerative colitis and controls.
    Ullrich R; Schneider T; Schieferdecker HL; Jahn HU; Riecken EO; Zeitz M
    Adv Exp Med Biol; 1995; 371B():1281-2. PubMed ID: 7502800
    [No Abstract]   [Full Text] [Related]  

  • 6. Road most traveled: gut-specific migration signals and leucocyte entry to the intestine.
    Grimm MC; Ng WS
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1775-6. PubMed ID: 19120867
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Crohn disease and ulcerative colitis - current status: pathologico-anatomic aspects].
    Haferkamp O
    Chirurg; 1981 Dec; 52(12):737-43. PubMed ID: 6459218
    [No Abstract]   [Full Text] [Related]  

  • 9. [Undefined chronic colitis with its patho-histologic differentiation from Crohn disease and ulcerative colitis].
    von Herbay A; Sinn P; Otto HF
    Z Gastroenterol Verh; 1989 Jul; 24():22-5. PubMed ID: 2474961
    [No Abstract]   [Full Text] [Related]  

  • 10. The incidence of colonic natural killer cells, large granular lymphocytes and mast cells in inflammatory bowel disease.
    Emmons LR; Schaub U; Hadziselimovic F
    Adv Exp Med Biol; 1995; 371B():1261-6. PubMed ID: 7502796
    [No Abstract]   [Full Text] [Related]  

  • 11. Automated classification of inflammation in colon histological sections based on digital microscopy and advanced image analysis.
    Ficsor L; Varga VS; Tagscherer A; Tulassay Z; Molnar B
    Cytometry A; 2008 Mar; 73(3):230-7. PubMed ID: 18228558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological aspects of inflammatory bowel disease.
    Deusch K; Reich K
    Endoscopy; 1992 Aug; 24(6):568-77. PubMed ID: 1396367
    [No Abstract]   [Full Text] [Related]  

  • 13. P-ANCA as a differential diagnostic marker in inflammatory bowel disease.
    Oberstadt K; Schaedel W; Weber M; Classen M; Deusch K
    Adv Exp Med Biol; 1995; 371B():1313-6. PubMed ID: 7502807
    [No Abstract]   [Full Text] [Related]  

  • 14. 4D5.4, a monoclonal antibody which recognizes cells in inflamed human intestine.
    Taylor J; MacDonald TT; Spencer J
    Adv Exp Med Biol; 1995; 371B():1331-2. PubMed ID: 7502811
    [No Abstract]   [Full Text] [Related]  

  • 15. [Morphological and immunological characteristics of various clinical forms of nonspecific ulcerative colitis].
    Avtandilov GG; Larchenko NT; Stenina MA; Loranskaia ID; Cheredeev AN
    Arkh Patol; 1984; 46(10):18-25. PubMed ID: 6334508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative immunohistochemical features of Crohn disease and ulcerative colitis].
    Ioffe AIu
    Lik Sprava; 2005; (5-6):33-5. PubMed ID: 16396288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunopathology of ulcerative colitis and granulomatous colitis (author's transl)].
    Bläker F
    Leber Magen Darm; 1975 Aug; 5(4):167-71. PubMed ID: 1223564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
    Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
    Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: A study by immunofluorescence of the intestinal mucosa in ulcerative colitis and Crohn's disease.
    Green FH; Fox H
    J Med Microbiol; 1973 Nov; 6(4):P18. PubMed ID: 4587399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.